Thanks for the detail, jondoeuk… I think what has the most appeal to me is making as much of the treatment from the patient themselves. Perhaps there is less risk of rejection? Plus it represents more exactly what the patient’s body is fighting, since it came from their body.
Are the TILs and the T cells ACHL autologous, as is DCVax?
You do it every time. It is absolutely NOT like ACHL. You just post about and sell shares in other companies.
NWBO can simultaneously, in the same machine, process cells from the patient, to generate the vaccine and the T cell mixture, and they can choose the most effective process for that cancer. It’s not just the same. And it has its own potential efficiencies.
But ACHL is not just the same. You’re just selling another company by making such spurious claims.